Sort
82,697 grants matching “vaccine development”
Adjuvant Development Program in the context of vaccines to protect against Y. pestis and Shigella.
$1,180,599University Of Maryland Baltimore · N01 · FY2018 · AI
CAP-IT Center for LNP RNA Immunoprevention
$1,180,595Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · U54 · FY2022 · CA
Conditionally replicating Mycobacterium tuberculosis vaccines
$1,180,499Sabine Ehrt · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · AI
The Johns Hopkins Fogarty AIDS International Training and Research Program
$1,180,170Chris Beyrer · Johns Hopkins University · D43 · FY2007 · TW
Vaccine and adjuvant Clinical GMP product development and DNA Technology platform enhancements
$1,180,089Trevor Smith · Wistar Institute · U19 · FY2023 · AI
Project-002
$1,180,070Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2020 · AI
Structure-Guided Design of Broadly Neutralizing Lassa Virus BiSpecific Antibodies
$1,180,007Luis Manuel Branco · Zalgen Labs, Llc · R01 · FY2023 · AI
Science in a Culture of Mentoring
$1,179,870Judith A James · Oklahoma Medical Research Foundation · P30 · FY2012 · GM
Preclinical development of a vaccine for Nipah virus
$1,179,782Thomas William Geisbert · University Of Texas Med Br Galveston · R01 · FY2022 · AI
Resource for Molecular Imaging Agents in Precision Medicine
$1,179,527Martin G Pomper · Johns Hopkins University · P41 · FY2021 · EB
Downstream sample analyses from 3 NHP species infected with SARS-CoV-2.
$1,179,314Joanne Turner · Texas Biomedical Research Institute · P01 · FY2020 · AG
Studies on Arthropod Vectors of Disease
$1,178,907Robert Gwadz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Novel Sensor Integrated Proteome on Chip (SPOC) platform for evaluating kinetic parameters of protein interactions in high throughput
$1,178,727Bharath Takulapalli · Spoc Proteomics Inc. · R44 · FY2022 · TR
Spirulina oral supplement for enhancing host resilience to virus infection
$1,178,516Ikhlas Ahmad Khan · University Of Mississippi · U19 · FY2023 · AT
Malaria Vaccine: Pfs25-Pvs25
$1,178,399Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
High-throughput proteomics using submicroliter amounts of plasma for comprehensive assessment of the immune status
$1,178,245Hanno Steen · Boston Children'S Hospital · U24 · FY2024 · AI
High-throughput proteomics using submicroliter amounts of plasma for comprehensive assessment of the immune status
$1,178,245Hanno Steen · Boston Children'S Hospital · U24 · FY2020 · AI
High-throughput proteomics using submicroliter amounts of plasma for comprehensive assessment of the immune status
$1,178,245Hanno Steen · Boston Children'S Hospital · U24 · FY2022 · AI
High-throughput proteomics using submicroliter amounts of plasma for comprehensive assessment of the immune status
$1,178,245Hanno Steen · Boston Children'S Hospital · U24 · FY2023 · AI
High-throughput proteomics using submicroliter amounts of plasma for comprehensive assessment of the immune status
$1,178,244Hanno Steen · Boston Children'S Hospital · U24 · FY2021 · AI
Towards high-resolution structural biology of membrane protein complexes in their native lipid environment
$1,178,067Doreen Matthies · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
CTL and HIV Polymorphisms in Heterosexual Transmission
$1,178,018Emory University · R01 · FY2005 · AI
Computational models of naturally acquired immunity to falciparum malaria
$1,177,782Bryan R Greenhouse · University Of California, San Francisco · U01 · FY2024 · AI
Structure-based design of novel Lassa virus glycoproteins for vaccine development
$1,177,630Robert F Garry · Tulane University Of Louisiana · R01 · FY2020 · AI
Virus-Host Interactions: Induction and Evasion of Host Innate Immunity
$1,177,597Sonja Best · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI